Chronic Obstructive Pulmonary Disease. Other chronic obstructive pulmonary disease
Conditions
Interventions
Intervention 1: Intervention group: in this group will be used a hot pack for topical heat therapy, a special 25×35 standard linen bag containing hydrophilic silicate and charged by a hydrocollator up
Sponsors
Gonabad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Stage of 1-4 in Chronic obstructive pulmonary disease according to GOLD criteria BMI between 18.5-25 kg/m2 Alertness, ability to speak and communicate Stable physiological status for answer questions
Exclusion criteria
Exclusion criteria: The presence of lesions (swelling, sores, scratches, and redness) in the chest area Structural disorder and deformity in the chest area The history of mental disorder and hyperthyroidism based on patient reports The presence of cardiac arrhythmia Spirometric contraindication conditions (uncontrolled hypertension, contagious respiratory infection, active hemoptysis, recent eye or ear surgery, rupture of tympan, the recent CVA or pulmonary embolism, the history of myocardial infarction or unstable angina in recent 6 weeks)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vital Capacity. Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Spirometry.;Force Vital Capacity. Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Spirometry.;Forced Expiratory Volume in First Second. Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Spirometry.;Peak Expiratory Flow Rate. Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Spirometry.;Forced expiratory flow at 25-75% of vital capacity. Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Spirometry.;FEV1/FVC. Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Spirometry.;Respiratory rate. Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Number per minute.;Oxygen saturation percentage (SPO2). Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Pulse Oximeter Device.;Fatigue severity. Timepoint: At baseline (before intervention), 6 days after first intervention. Method of measurement: Crop questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasume ??Shahpasand
Gonabad University of Medical Sciences
Outcome results
None listed